Kaleido Shares Crater as Company Ceases Operations

Kaleido Biosciences shares cratered, falling 76% in early trading Friday after the company disclosed in a regulatory filing that its board agreed to wind down and cease all operations—as part of which Kaleido will de-list its shares from The Nasdaq Stock Market. Kaleido has…

Source: www.genengnews.com – Read more